A systematic review of LDL apheresis in the treatment of cardiovascular disease

被引：61
|
作者：
Thompsen, Jeff [1 ]
Thompson, Paul D. [1 ]
机构：
[1] Hartford Hosp, Ishikari, Hokkaido 06102, Japan
来源：
ATHEROSCLEROSIS | 2006年 / 189卷 / 01期
关键词：
apheresis; LDL apheresis; cholesterol; LDL cholesterol; atherosclerosis; coronary artery disease;
D O I：
10.1016/j.atherosclerosis.2006.02.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LDL apheresis is an effective method of lowering low-density lipoprotein (LDL) concentration in patients with familial hypercholesterolemia (FH) who are either refractory to treatment or intolerant of medical therapy. We searched the medical literature through July 2004 using PubMed and Medline and the search terms "LDL apheresis", "cardiovascular", and "disease" to identify apheresis techniques and to evaluate their effects on cardiovascular pathophysiology and clinical outcomes. We conclude that LDL apheresis reduces cardiovascular events in hypercholesterolemic patients and may be an effective treatment for other vascular diseases including cholesterol embolic disease, focal segmental glomerular sclerosis, sudden hearing loss, and age-related macular degeneration. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：31 / 38
页数：8
相关论文
共 50 条
  • [1] LDL Apheresis for the Treatment of Familial Hypercholesterolemia. A Systematic Review
    Zechmeister, Ingrid
    Mathis, Stefan
    Guba, Beate
    Gartlehner, Gerald
    MEDIZINISCHE KLINIK, 2009, 104 (01) : 1 - 9
  • [2] 26 Years of LDL-Apheresis: A review of experience
    Borberg, H.
    TRANSFUSION AND APHERESIS SCIENCE, 2009, 41 (01) : 49 - 59
  • [3] LDL Apheresis and Lp (a) Apheresis: A Clinician's Perspective
    Kayikcioglu, Meral
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (04)
  • [4] Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study
    Stefanutti, C.
    D'Alessandri, G.
    Russi, G.
    De Silvestro, G.
    Zenti, M. G.
    Marson, P.
    Belotherkovsky, D.
    Vivenzio, A.
    Di Giacomo, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (05) : 89 - 94
  • [5] Long term results of the treatment of severe hyperlipidemia by extracorporal LDL-elimination (LDL-apheresis)
    Schiel, R
    Bambauer, R
    Latza, R
    Klinkmann, J
    MEDIZINISCHE WELT, 1996, 47 (08): : 313 - 318
  • [6] Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
    Chary, Abdolreza
    Tohidi, Maryam
    Hedayati, Mehdi
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [7] LDL apheresis: An effective and safe treatment for refractory hypercholesterolemia
    Hudgins, LC
    Gordon, BR
    Parker, TS
    Saal, SD
    Levine, DM
    Rubin, AL
    CARDIOVASCULAR DRUG REVIEWS, 2002, 20 (04): : 271 - 280
  • [8] THE EFFECT OF LDL APHERESIS ON PROGRESSION OF CORONARY-ARTERY-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - RESULTS OF A MULTICENTER LDL APHERESIS STUDY
    WAIDNER, T
    FRANZEN, D
    VOELKER, W
    RITTER, M
    BORBERG, H
    HOMBACH, V
    HOPP, HW
    CLINICAL INVESTIGATOR, 1994, 72 (11): : 858 - 863
  • [9] Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care
    Stefanutti, C.
    Vivenzio, A.
    Di Giacomo, S.
    Mazzarella, B.
    Ferraro, P. M.
    Abbolito, S.
    TRANSFUSION AND APHERESIS SCIENCE, 2010, 42 (01) : 21 - 26
  • [10] Systematic review and meta-regression on the duration of LDL-C lowering and major adverse cardiovascular events
    Redel-Traub, Gabriel
    Smilowitz, Nathaniel R.
    Xia, Yuhe
    Berger, Jeffrey S.
    VASCULAR MEDICINE, 2022, 27 (04) : 375 - 376
12345